Venture capital firm based in London, UK
Curve Therapeutics, backed by $40.5M in funding from industry giants like Pfizer Ventures, is revolutionizing drug discovery to tackle complex diseases and push the boundaries of biotechnology. Read more
With a groundbreaking $100 million funding boost, Manchester's F2G is set to revolutionize the fight against invasive fungal infections with its pioneering drug, olorofim! Read more
Healthtech | 50.0% |
Biotech | 50.0% |